Kraj: Wielka Brytania
Język: angielski
Źródło: VMD (Veterinary Medicines Directorate)
Feline leukemia virus
Zoetis UK Limited
–QI06A
Feline leukemia virus
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cats
Inactivated Viral Vaccine
Authorized
2005-10-28
Revised: May 2020 AN: 00066/2020 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Leukocell 2 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose (1ml) of Leukocell 2 contains the following ACTIVE SUBSTANCES: Inactivated sub-unit antigens (gp 70 and FOCMA) of feline leukaemia virus (FeLV) sub-types A, B and C: _minimum: 2266 ng/ml of gp70 antigen._ EXCIPIENTS: Alhydrogel 2 % 50 μl Quil A 25 μg Thiomersal 0.115 mg (maximum) See Section 6.1 for full list of excipients. 3. PHARMACEUTICAL FORM Solution for injection. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats from 9 weeks of age. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Active immunisation of cats to reduce persistent viraemia and lymphoid tumours caused by FeLV infection, and thereby to reduce other diseases associated with FeLV infection. Onset of immunity occurs by approximately 3 weeks after the last dose of the Basic Vaccination Scheme. The duration of immunity is at least 12 months. 4.3 CONTRAINDICATIONS Unhealthy animals should not be vaccinated. Revised: May 2020 AN: 00066/2020 Page 2 of 4 The use of immunosuppressant drugs or procedures within one month of vaccination is contra-indicated. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES If an anaphylactic reaction occurs, institute treatment according to the clinical signs using adrenaline or other appropriate medication. Vaccination is of no known clinical value in cats with pre-existing FeLV infection, nor will it change the natural course of the disease. The effect of maternally derived antibodies (MDA) on the response to vaccination is not known, but on the basis of published data and field use it is expected that the levels of MDA that will be present at 9 weeks of age will not interfere with the response to vaccination. 4.5 SPECIAL PRECAUTIONS FOR USE i) Special precautions for use in animals None. ii) Special precautions to be taken by the person administering the veterinary medicinal product to animals In case of accidental self-injection, Przeczytaj cały dokument